Industry

LAUSANNE, Switzerland–(BUSINESS WIRE)–Gnubiotics Sciences, a biotech company pioneering the discovery and development of immunomodulatory glycopeptides, today announced that the Swiss Innovation Agency (Innosuisse) will support a research collaboration with the University Hospital Zürich to accelerate the development of Gnubiotics’ GLAAD technology in a range of solid tumors. The total project cost of CHF 1.4 million … [Read more…]

INGELHEIM, Germany & HAMBURG, Germany & MARCY-L’ÉTOILE, France–(BUSINESS WIRE)–Boehringer Ingelheim, a leading research-driven biopharmaceutical company, the life science company Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and bioMérieux, a world leader in in vitro diagnostics, announced today that they have formed a joint venture to create the next generation of antimicrobials … [Read more…]

BRANFORD, Conn. & NESS ZIONA, Israel–(BUSINESS WIRE)–BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, announced today that it is voluntarily delisting its shares of common stock from trading on the Tel Aviv Stock Exchange (the “TASE”). Based upon … [Read more…]

– Mosunetuzumab could be the first CD20xCD3 T-cell engaging bispecific antibody approved by the FDA for the treatment of any type of non-Hodgkin’s lymphoma – – Application is based on results from the pivotal Phase I/II study showing mosunetuzumab induced high and durable complete response rates in people with follicular lymphoma who received two or … [Read more…]

Pfizer and Touchlight agree to patent license for Pfizer to utilise rapid, scalable, enzymatic doggybone DNA (dbDNA) in Pfizer’s clinical and commercial manufacture of its mRNA vaccines, therapeutics, and gene therapies Agreement includes upfront payment, potential development and commercial milestone payments, and royalties upon commercialization Access to dbDNA patent rights enables Pfizer’s rapid production of … [Read more…]

CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (Nasdaq: CERS) today announced the appointment of Hua Shan, MD, PhD, Professor of Pathology and Medical Director, Transfusion Medicine Service at Stanford Medical Center to its Board of Directors. “We are pleased to welcome Dr. Shan to Cerus’ Board of Directors,” said Daniel Swisher, Chair of the Board. “Dr. Shan is … [Read more…]

Wilensky Appointed Chair and Blanck Joins HJF’s Council of Directors BETHESDA, Md.–(BUSINESS WIRE)–#militarymedicine–The Honorable Gail R. Wilensky, Ph.D., has been appointed Chair of The Henry M. Jackson Foundation for the Advancement of Military Medicine’s (HJF) Council of Directors (CoD). Dr. Wilensky, an economist and senior fellow at Project Hope, has been with HJF’s CoD since … [Read more…]

Members of the U.S. House and Senate Sent Letters to the Federal Administration Advocating for Greater Access to Dental Care Under Medicare BOSTON–(BUSINESS WIRE)–Today, CareQuest Institute for Oral Health® — a leading national nonprofit focused on creating a more accessible, equitable, and integrated oral health system — applauded members of the U.S. Senate and House … [Read more…]

DENVER–(BUSINESS WIRE)–All Clear Foundation is a national nonprofit dedicated to supporting the wellbeing of the Emergency Responder community. The cumulative stress and trauma of Response work, whether in the field or medical setting, can erode a Responder’s health, wellness, and relationships. Many, unfortunately, experience a decreased personal quality of life as a consequence of the … [Read more…]

OAKLAND, Calif.–(BUSINESS WIRE)–#CWCI–Payments for medical-legal services used to resolve medical disputes over compensability issues in California work injury claims have risen sharply under the new Medical-Legal Fee Schedule (MLFS) that took effect last year according to a new CWCI study, with the increase in aggregate med-legal fees in the first seven months after the schedule … [Read more…]